Tumor-bone interactions in skeletal metastasis - PubMed (original) (raw)
Affiliations
- PMID: 7634602
Review
Tumor-bone interactions in skeletal metastasis
F W Orr et al. Clin Orthop Relat Res. 1995 Mar.
Abstract
Bone metastases are a frequent clinical problem in patients with breast, prostate, and other cancers. Formation of these lesions is a site-specific process determined by multiple cellular and molecular interactions between the cancer cells and the bone microenvironment. Clinical studies, and in vivo and in vitro experimental approaches, have been useful to dissect different stages of this process. Mechanisms identified as relevant to cancer spreading and tumoral growth in the bones include (a) early vascular spread of cancer cells to bones; (b) adhesion of cancer cells to the bone microvasculature and matrix components; (c) presence of growth factors and chemo-attractants in bone; (d) osteolysis by osteoclasts, tumor associated macrophages, and cancer cells; and (e) tumor-induced local osteoblastic proliferation. Although none of these mechanisms alone are responsible for the development of bone metastases, their investigation may lead to novel therapeutic approaches that specifically block these stages and, thus, may hinder development of bone metastasis. The use of bisphosphonates and other experimental strategies already is being tested in clinical trials.
Similar articles
- Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW, Baseman A, Assikis V, Zhau HE. Chung LW, et al. J Urol. 2005 Jan;173(1):10-20. doi: 10.1097/01.ju.0000141582.15218.10. J Urol. 2005. PMID: 15592017 Review. - Pathophysiology of bone metastases: how this knowledge may lead to therapeutic intervention.
Lipton A. Lipton A. J Support Oncol. 2004 May-Jun;2(3):205-13; discussion 213-4, 216-7, 219-20. J Support Oncol. 2004. PMID: 15328823 Review. - Targeting factors involved in bone remodeling as treatment strategies in prostate cancer bone metastasis.
Vessella RL, Corey E. Vessella RL, et al. Clin Cancer Res. 2006 Oct 15;12(20 Pt 2):6285s-6290s. doi: 10.1158/1078-0432.CCR-06-0813. Clin Cancer Res. 2006. PMID: 17062715 Review. - Tumor-bone cellular interactions in skeletal metastases.
Chirgwin JM, Mohammad KS, Guise TA. Chirgwin JM, et al. J Musculoskelet Neuronal Interact. 2004 Sep;4(3):308-18. J Musculoskelet Neuronal Interact. 2004. PMID: 15615499 Review. - Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone.
Clines GA, Guise TA. Clines GA, et al. Endocr Relat Cancer. 2005 Sep;12(3):549-83. doi: 10.1677/erc.1.00543. Endocr Relat Cancer. 2005. PMID: 16172192 Review.
Cited by
- Regression of bone metastases following adoptive transfer of anti-CD3-activated and IL-2-expanded tumor vaccine draining lymph node cells.
Rüttinger D, Li R, Urba WJ, Fox BA, Hu HM. Rüttinger D, et al. Clin Exp Metastasis. 2004;21(4):305-12. doi: 10.1023/b:clin.0000046139.59515.4e. Clin Exp Metastasis. 2004. PMID: 15554386 - Loss of P53 facilitates invasion and metastasis of prostate cancer cells.
Wang Y, Zhang YX, Kong CZ, Zhang Z, Zhu YY. Wang Y, et al. Mol Cell Biochem. 2013 Dec;384(1-2):121-7. doi: 10.1007/s11010-013-1789-1. Epub 2013 Aug 28. Mol Cell Biochem. 2013. PMID: 23982184 - Chemical and Biochemical Basis of Cell-Bone Matrix Interaction in Health and Disease.
Feng X. Feng X. Curr Chem Biol. 2009 May 1;3(2):189-196. doi: 10.2174/187231309788166398. Curr Chem Biol. 2009. PMID: 20161446 Free PMC article. - NG-nitro-L-arginine methyl ester inhibits bone metastasis after modified intracardiac injection of human breast cancer cells in a nude mouse model.
Iwasaki T, Higashiyama M, Kuriyama K, Sasaki A, Mukai M, Shinkai K, Horai T, Matsuda H, Akedo H. Iwasaki T, et al. Jpn J Cancer Res. 1997 Sep;88(9):861-6. doi: 10.1111/j.1349-7006.1997.tb00462.x. Jpn J Cancer Res. 1997. PMID: 9369934 Free PMC article. - A-Disintegrin and Metalloproteinase (ADAM) 17 Enzymatically Degrades Interferon-gamma.
Kanzaki H, Shinohara F, Suzuki M, Wada S, Miyamoto Y, Yamaguchi Y, Katsumata Y, Makihira S, Kawai T, Taubman MA, Nakamura Y. Kanzaki H, et al. Sci Rep. 2016 Aug 30;6:32259. doi: 10.1038/srep32259. Sci Rep. 2016. PMID: 27573075 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical